Fatty acids form the major fuels for energy production of working heart and of skeletal muscle at rest and during moderate and prolonged exercise. Only a small proportion of fatty acids taken up by muscle is used for anabolic processes such as triacylglycerol and phospholipid synthesis, in contrast to adipose tissue and liver. Blood-borne fatty acids are delivered to muscle bound to albumin or from triacylglycerols in chylomicrons and very-low-density lipoproteins after hydrolysis by lipoprotein lipase. The fatty acids are very effectively extracted by the heart from blood, 40-60% during one transmit time (Opie et al., 1973) , although they have to pass many barriers and compartments to reach the myocyte mitochondrion, where their main utilization (oxidation) takes place ( acids to the interstitial space. Some fatty acids may also enter together with albumin through the endothelial clefts or through an intra-endothelial channel system of fused vesicles (Sejrsen et a/., 1985) . Albumin is present in the extracellular fluid (Yokota, 1982; Reed, 1985) and is probably involved in fatty acid binding and transport in this space (Julien et a/., 1978) . The higher transcapillary extravasation rate of albumin during activity of rat muscle (Reed, 1985) may be important in this respect.
The mechanism of the fatty acid transport from capillary to myocyte is still unclear. Wetzel & Scow (1984) proposed, on the basis of electron microscopic studies, that fatty acids would be transported by lateral movement in cell membranes in a continuum across the capillary endothelium and within myocytes, but there is no evidence for complete continuity, e.g. between the external leaflets of the plasma membranes of endothelial cells and myocytes.
The rate of fatty acid uptake by the peripheral tissues will depend on the concentration of the fatty acids in the blood, their intracellular concentration and their rate of utilization. The fatty acid/albumin ratio determines the concentration of unbound fatty acid (Spector et al., 1971; Wosilait & Soler-Argilaga, 1977 ). An increase in this ratio increases the uptake of fatty acid by the perfused rat heart (Evans et a/., , 1978; Hagenfeldt & Wahren, 1968) . Increased ventricular pressure development in rat heart results in an increased rate of fatty acid oxidation and an accelerated fatty acid uptake due to an increased concentration gradient (Oram rt al., 1973) . Total and also individual fatty acids (except arachidonic acid) show a marked serum-tissue gradient in hearts of rat, dog and man (Rose & Goresky, 1977; Van Der Vusse et ul., 1983) The study of muscle uptake is complicated by a simultaneous release of fatty acids from endogenous triacylglycerols (Have1 et al., 1967; Crass, 1977) . The rate of cellular uptake of fatty acid in muscle is influenced by the magnitude of the total resistance to fatty acid movement. This resistance is determined by the rate of blood flow. the solubility of the fatty acid, its binding to albumin and its rate of diffusion across a series of (unstirred) water compartments and cell membranes (Dietschy, 1978) . Since the passive permeability coefficient of a long-chain fatty acid in membranes is high, it is likely that in vivo one rate-limiting step in fatty acid uptake is diffusion across the various complex diffusion barriers between the blood or intramuscular adipocyte and the myocyte.
Dissociation from albumin could also be a rate-limiting step in the uptake of fatty acids, when the albumin concentration is such that most fatty acid is bound, but small enough that binding equilibrium is not present (Weisiger, 1985) . When the fatty acid/albumin molar ratio is fixed the concentration of unbound fatty acid rises first steeply with increasing total fatty acid concentration but then becomes almost constant. The fatty acid uptake in cultured cardiac cells, hepatocytes, diaphragm and perfused rat heart shows a saturation curve with increasing total fatty acid concentration (Paris et al., 1978; Ockner et al., 1983; Glatz & Veerkamp, 1982; Hutter rt al., 1984) . When the albumin concentration is constant (as usually is the case in serum) and the fatty acid concentration varies, the concentration of unbound fatty acid rises over a much larger range than the total concentration (Salmon & Flatt, 1979) . The uptake is then related to total fatty acid concentration up to high concentrations.
Kinetic studies suggest an albumin receptor-mediated uptake (Ockner et al., 1983; Hutter et al., 1984; Fleischer et al., 1986) . However, the albumin concentrations used in these studies are low compared with its serum concentration. I t remains to be established if dissociation of the fatty acid from albumin is rate-limiting to uptake under physiological conditions, although saturable binding of albumin to liver cells was demonstrated (Weisiger, 1985) . The dissociation process does not appear to limit fatty acid uptake in the perfused liver (Noy et ul., 1986) . The tight binding of fatty acids to albumin may ensure that fatty acids will not markedly be released in the big vessels where blood flows rapidly and that the bulk of the fatty acids will be released where flow is sluggish, as in the capillaries (Daniels et al., 1985) .
The lipophilic character of fatty acids suggests that these compounds might easily diffuse through the phospholipid bilayer of the plasma membrane (Dietschy, 1978) . Movement of 9-anthroyloxy-labelled long-chain fatty acids between unilamellar vesicles is, however, primarily determined by the rate of transbilayer movement, which has a rate one-tenth of the transfer from the outer leaflet to the water phase (Storch & Kleinfeld, 1986 ). Stremmel rt ai. (I985a,b) isolated a fatty acid-binding protein from plasma membranes of rat liver and jejunum. The protein had a molecular mass of 40 kDa and a PI of 9.0. I t showed a high affinity for fatty acids, but not for phospholipids, cholesterol esters and other classes of albumin-bound organic anions. A rabbit antibody to this protein inhibited fatty acid uptake in hepatocytes (Stremmel & Theilmann. 1986 ). The antibody also showed specific immunofluorescence with intercalated discs of cardiac muscle (Stremmer ct d., 1985a).
The occurrence of such a protein could, however. not be established by us in porcine heart sarcolemma ( J . H . Veerkamp. unpublished work).
In conclusion, the existence of an albumin receptor and/ or a plasma membrane fatty acid-binding protein in cardiac and skeletal muscle requires experimental evidence. The mechanism of fatty acid uptake and the nature of the ratedetermining step(s) is not clear in muscle, unlike in other systems. The interaction of fatty acid transport with oxidation is demonstrated by the different kinetic parameters of palmitate oxidation in various muscle systems (Table I) . Complex systems such as intact muscles and slices show a higher apparent K,,, value than isolated cells and homogenates. This indicates a limitation by intercellular fatty acid transport. Uptake does not appear to be rate-limiting for cultured human muscle cells and rat flexor myofibres.
In tracc~llular transport und. fut t! ucid-binding protein
The uptake of fatty acids will also depend on their transport and utilization within the cell. Release from the inner half of the plasma membrane and diffusion to cell organelles may take place as fatty acids solvated by water or bound to a cytosolic I4kDa protein named the intracellular fatty acid-binding protein (FABP) (Ockner et al., 1972) . The significance of this protein for intracellular fatty acid transport is still under discussion. The flux due to the free fatty acid could be augmented by a second flux due to the proteinbound fatty acid (Tipping & Ketterer, 1981) . The latter form may contribute significantly to total intracellular fatty acid flux, if the protein is present in a high concentration and has a moderate affinity. Another requirement is that the rates of dissociation of the FABP-fatty acid and membrane-fatty acid complexes are rapid compared with the diffusion processes. When the latter is not the case, FABPs may facilitate the release of fatty acids from membranes (Doody et ul., 1980; Daniels et al., 1985) .
The FABPs may store fatty acids (Rose & Goresky, 1977; Goresky c/ al., 1978) and in this way expand the intracellular pool of free fatty acids. A large fraction of cytosolic free fatty acids is bound to FABP in liver (Ockner et al., 1982) . FABPs may also sequestrate fatty acids and their CoA and carnitine esters, and in this way regulate the concentration of these compounds as substrate, modulator or inhibitor 01' certain ezymes or transport systems (reviewed in Glatz & Veerkamp, 1985) . The role of the FABPs in the different cell types remains to be established. A specific role of this protein in heart may be protection against the fatty acids and long-chain acyl-CoA and acyl-carnitine esters that accumulate during ischaemia and hypoxia (Katz & Messineo, 1981; Corr et al., 1984) .
Dctection and physic~ochcmical characteristics
Ockner ct 01. (1972) and Mishkin et al. (1972) demonstrated, by co-elution of labelled fatty acid and protein on gel filtration, for the first time that the cytosol of rat and human heart and of rat skeletal muscle contains a low-M, FABP. Reaction of heart cytosol with antibodies against liver or intestinal FABP (Ockner & Manning, 1974; Kamisaka ('t d.. 1981; Rustow et al., 1982) and the inhibition of palmitate uptake in perfused dog heart by a-bromopalmitate (Rose & Goresky, 1977) also suggested the presence of FABP in heart. Gloster & Harris (1977) found binding activity in cytosol from heart of rat, guinea pig and rabbit and from red skeletal muscle. but not from white muscle, of rat. On the basis ofco-elution. they proposed that myoglobin could play a role in fatty acid binding. Testing of column fractions and of protein on fatty acid-binding activity can, however, better be done with the Lipidex procedure (Glatz (it ul., 19840) .
Purification of FABP from heart of various mammals provided evidence that heart FABP was an acidic protein not identical with myoglobin (Fournier et al., 1978; Said & Schulz. 1984; Glatz PI al., 1985a,h; Jagschies et al., 1985;  R. J. A. Paulussen & J. H . Veerkamp. unpublished work). Liver and heart FABP are also different molecules. The antiserum directed against rat liver FABPdid not cross-react with FABP from rat heart (Said & Schulz, 1984) ; antiserum against rat heart FABP did not cross-react with liver FABP (Offner ct al., 1986) . We have repeated both observations. The amino acid composition and isoelectric point of FABPs from rat liver and heart appeared to be different (Glatz ct al., 19850; Offner et al., 1986) . FABP from human liver (Chan ct ul., 1985; Lowe et al., 1985 , Kamisaka et al., 1981 also differs in these respects from human heart FABP. The latter molecule contains no cysteine and has a lower pl value (R. J. A. Paulussen & J. H . Veerkamp, unpublished work). Cardiac and liver FABPs from cattle were also clearly different with regard to their amino acid composition, immunogenic determinants and physicochemical characteristics (Jagschies PI al., 1985) . Recently, the primary structure of rat heart FABP was elucidated by Edman degradation of peptides generated by enzymic digestions (Sacchettini et a/., 1986). The heart FABP molecule has more homology with other proteins which bind hydrophobic ligands, than with liver and intestinal FABP. The rank of order of similarity with heart FABP is: adipocyte 422 protein > myelin Pz > cellular retinoic acid-binding protein > cellular retinol-binding protein > intestinal FABP > liver FABP (Sacchettini et (11.. 1986 ). All these proteins lack homology Vol. 15 with serum albumin and phospholipid-transfer proteins .
The secondary structure studied by circular dichroism was comparable (about 48% /?-sheet, 8% fi-turn, 18% ahelix and 25% random coil) for FABPs from pig, bovine and rat heart Jagschies et al., 1985; Offner et a/., 1986) . The concentration-dependent selfaggregation observed for pig heart FABP Fournier & Rahim, 1983) was not found for the FABPs from rat or bovine heart by other investigators.
The oleic acid-binding capacity amounted to 4.4 nmol/mg of cytosolic protein in rat heart (Paulussen et al., 1986) . Immunological analysis gave a comparable FABP concentration of 0.3 pmol/g of tissue wet weight (Fournier & Rahim, 1985) or 3.4nmol/mg of cytosolic protein (Bass & Manning, 1986) .
Isolation of FABP from skeletal muscle has not been described up until now. Said & Schulz (1985) reported that FABP of rat skeletal muscle was immunologically related to heart FABP, but showed difference with respect to ultraviolet spectrum, electrophoretic mobility and fatty acid binding. Based on its Ca2+ content, PI value, amino acid composition and ultraviolet spectrum it should be identical with, or at least closely related to, parvalbumin. The content of this intracellular Ca2+ -binding proteing is, however, 200-300-fold higher in fast-than in slow-twitch muscles (Heizman, 1984; Leberer & Pette, 1986 ). This protein is probably involved in the relaxation of muscle. Its distribution does not suggest a role in fatty acid metabolism, since the fatty acid oxidation capacity is higher in slow-than in fast-twitch muscles (Hooker & Baldwin, 1979; Veerkamp et al., 1983; Zuurveld et al., 1985) . We isolated a I4kDa fatty acid-binding protein from rat quadriceps muscle by gel filtration on Sephacryl S-200 and chromatography on DEAE-Sephacel. This protein had a pl of 5.2 and differed from heart FABP in amino acid composition.
With a co-elution procedure Smith et al. (1985) and St. John et al. (1986) found a palmitoyl-CoA binding of only 35pmol/mg of protein and absence of binding in cytosols from skeletal muscle of cattle and pig, respectively. Cytosol from rat quadriceps muscle bound 1.6 nmol of fatty acid/mg of protein (Paulussen et al., 1986) and that from human m. gluteus 2.2 nmol/mg of protein. In the latter assays Lipidex 1000 was used to separate protein-bound and unbound fatty acids.
Binding properties of',fatty acid-binding proteins
I t can be calculated from the endogenous cytosolic content of protein-bound fatty acids and the FABP content in rat heart and liver, that less than 50% of the FABP molecules are occupied (Glatz et d., 1984~) . The endogenous fatty acids of rat liver and bovine heart FABP are mainly unsaturated (70-85%) and especially polyunsaturated (50-75%) (Burnett et al., 1979; Ockner et al., 1982; Jagschies, 1984) . The significance of these observations remains to be established.
Various fatty acids appear to bind to heart cytosol (Mishkin et d., 1972) and to purified FABP preparations from heart (Glatz et al., 1985b) . Fournier et ul. (1978) reported the binding of stearic acid and 12-doxyl-stearic acid to rat heart FABP. The binding of the latter fatty acid to pig heart FABP was dependent on the protein concentration and the maximum was 0.2mol/mol (Fournier ct al., 1983) . Bovine heart FABP bound up to 1 mol of fatty acid/mol (Jagschies et al., 1985) like rat liver and heart FABPs (Glatz et al., 1985~) . Table 2 shows the binding properties of heart FABP preparations measured with the Lipidex procedure (Glatz et al., 1985~) . The molar ratios are less than 1 .O, possibly due to the low protein concentration used during the assay. The binding affinity is higher for oleic and arachidonic acid than for palmitic acid, as was also observed for bovine heart FABP (Jagschies, 1984) . The binding affinity for palmitoyl-CoA and palmitoyl carnitine was comparable with that of palmitic acid with human and rat heart FABPs (data not shown). With a binding assay, which measures the transfer of fatty acids between donor liposomes and FABP, a Kd for palmitic acid of about 15 PM (Brecher et al., 1984) and a ratio of 1.8-2.0 (Offner et al., 1986) was found. We could not repeat these observations and found a ratio of up to 1.5 at a protein concentration of The binding of (9'-anthroyloxy)palmitic acid by bovine heart FABP was weak compared with bovine liver FABP. The latter removes the ligand from vesicles, whereas bovine heart FABP will only donate the fatty acid to vesicles (Reers et ul., 1984) . Recently, the inability of rat heart FABP to transfer fatty acid from mukilamellar hposomes to h e r microsomes was observed (McCormack et al., 1986) . Rat liver and heart FABP both bound fatty acid, but only the former increased acyl-CoA formation. It has not been reported that ligands other than fatty acids and their derivatives bind to heart FABP. Lysolecithin binds to liver FABP, but not to heart FABP (Burrier & Brecher, 1986) . Cholesterol and bilirubin do not inhibit oleic acid binding to heart FABP (R. J . A. Paulussen & J . H. Veerkamp, unpublished work).
Physiological significance of FABP
Heart FABP does not show marked adaptations to variations in physiological conditions. Postnatal development had no influence on the FABP content of rat heart (Paulussen et al., 1986) in contrast to its effect on palmitate oxidation capacity (Veerkamp & Van Moerkerk, 1986) . Starvation, clofibrate treatment and sex difference did not markedly change the fatty acid-binding capacity of rat heart in contrast to that of liver (Paulussen et al., 1986) . Increase in the fat content of the diet also had a minor effect on heart FABP content (Fournier & Rahim, 1985) . Fournier & Rahim (1985) observed a gradient-like subcellular distribution of FABP in rat heart with immunocytochemical detection by the protein A-gold method. The protein was detected on the myofibrils (7mg/ml), in the perimitochondrial space (2.8 mg/ml) and in the mitochondria (2.2 mgiml), but also in the capillary endothelium and in the intercellular space. The presence of FABP in the 4 pM.
latter space is interesting for intercellular transport, but remains to be confirmed. The investigators observed a competition for the fatty acid between mitochondria1 membranes and FABP. The fatty acid pool bound to FABP provides the fatty acid for the /Y-oxidation system. Selfaggregation of FABP and its gradient-like distribution may act as effector mechanisms in the regulation of fatty acid oxidation (Fournier & Rahim, 1985) . Fatty acids bound to heart FABP are well oxidized by rat heart mitochondria (Fournier et al., 1978; Glatz et al., 19856; Fournier & Rahim, 1985) . We have also liberated FABP (determined by specific immunoassay) from rat liver and heart mitochondria isolated in sucrose medium by subsequent treatment with a salt solution.
Imm unochemical in vest iga t ions
The binding assay quantifies the total fatty acid-binding capacity of a tissue cytosol. Immunochemical analysis with specific antibodies may give information on the molecular form(s) of FABP in the tissues. At least three types of FABP occur in the rat (liver, intestinal and heart FABP), but two distinct forms may be present in one tissue (e.g. intestinal and liver forms in intestine) (Bass, 1985; Glatz & Veerkamp, 1985) . A small amount of FABP in rat and human heart was previously detected with antibodies against liver or intestinal FABP preparations (Ockner & Manning, 1974; Kamisaka et al., 1981; Riistow et al., 1982) . Rat heart and some other rat tissues contain low levels of both mRNAs of intestinal and liver FABPs (Gordon et ul., 1985) , but Bass & Manning (1986) using immunodiffusion analysis with specific antibodies found only expression of liver FABP in liver and intestine and of intestinal FABP in intestine and stomach. Heart FABP was not detected in either liver or intestine but was present in stomach, kidney, ovary, testis and brain at levels 2-7% of those found in heart. Abdominal wall, white vastus lateralis and soleus muscle contained heart FABP at 6, 7 and 70%, respectively. of heart levels.
The high fatty acid-binding activities in rat tissues other than liver and heart (Paulussen et al., 1986) are not in accordance with the immunochemical data. Isolation of FABPs from muscle and other tissues may provide information about the possible occurrence of more tissue-specific forms. We purified FABP from rat liver, heart and quadriceps muscle, from human heart and quadriceps muscle, and from pig heart by gel filtration on Sephacryl S200 and Veerkamp, unpublished work) and raised specific antibodies in rabbits. Antibodies against FABP preparations from rat liver, heart and muscle only reacted with their original antigen in an enzyme-linked immunosorbent assay. Antisera against FABPs from human heart and quadriceps muscle and pig heart showed cross-reactivity. The antisera obtained were used to investigate reactivity of cytosolic proteins from various rat, human and pig tissues. Only cytosols from rat liver and intestine reacted with anti-rat liver serum. Th reactivity of cytosolic proteins from various muscles is given in Table 3 . The different rat skeletal muscles show a divergent pattern of reaction, which has to be confirmed with purified fractions of cytosols. The occurrence of a specific skeletal muscle FABP besides heart FABP, however, appears to be clear from these studies.
Conclusions. Heart and skeletal muscle of mammals contain a rather high content of FABP(s), 4-6% of cytosolic protein. Changes of physiological conditions do not markedly affect the FABP content of heart, in contrast to that of liver. The presence of various FABP forms in tissues and muscles suggests an adaptation to specific functions. The availability of pure FABP preparations from various tissues and of their antisera allow more adequate studies of their function(s) in the cell. The significance of FABPs in intracellular fatty acid and lipid metabolism remains to be established and also their regulatory and protective role in normal and pathological cellular metabolism is unclear. A deficiency of FABP or a structural mutation has not been described up to now, but detection of such a phenomenon may help to elucidate the role of FABPs in muscle and other tissues in the future.
